← Back to Search

Vaccine

Sucrose for Vaccination Pain Management

Phase 3
Waitlist Available
Led By Anna Taddio, PhD
Research Sponsored by Anna Taddio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
healthy infants receiving rotavirus vaccine in conjunction with primary immunizations in the first 6 months of life
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after vaccination in 1 minute
Awards & highlights

Study Summary

This randomized trial will compare the analgesic effectiveness of oral rotavirus vaccine to sugar water for reducing vaccine injection pain in infants.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after vaccinations in 1 minute
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after vaccinations in 1 minute for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Fetal Distress
Other outcome measures
Safety
Satisfaction

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SucroseExperimental Treatment1 Intervention
Sucrose prior to vaccine injections
Group II: RotavirusActive Control1 Intervention
Rotavirus prior to vaccine injections
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sucrose
FDA approved

Find a Location

Who is running the clinical trial?

Anna TaddioLead Sponsor
Anna Taddio, PhDPrincipal InvestigatorUniversity of Toronto
16 Previous Clinical Trials
18,560 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~11 spots leftby Apr 2025